St. Jude Medical (STJ) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Canaccord Genuity Cuts Price Target on St. Jude Medical (STJ) Following In-Line 3Q Results
October 22, 2015 10:09 AM EDTCanaccord Genuity maintained a Sell rating on St. Jude Medical (NYSE: STJ), and cut the price target to $59.00 (from $64.00), following the company's 3Q15 earnings results. While Q3 top- and bottom-line performance was largely in line with expectations, there was notable weakness in several key... More
Stifel Downgrades St. Jude Medical (STJ) to Hold
October 22, 2015 7:08 AM EDTStifel downgraded St. Jude Medical (NYSE: STJ) from Buy to Hold and removed its price target (prior $89.00).
For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.
Shares of St. Jude Medical closed at $62.30 yesterday.
... More